MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 563113 | Name: SW116

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SW116 is a fluorescent sigma-2 selective ligand.

Chemical Structure

SW116
SW116
CAS#1421931-13-6

Theoretical Analysis

MedKoo Cat#: 563113

Name: SW116

CAS#: 1421931-13-6

Chemical Formula: C39H56N4O6S

Exact Mass: 708.3921

Molecular Weight: 708.95

Elemental Analysis: C, 66.07; H, 7.96; N, 7.90; O, 13.54; S, 4.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
SW116; SW-116; SW 116;
IUPAC/Chemical Name
(2,5-Dimethoxy-phenyl)-carbamic acid 9-[10-(5-dimethylamino-naphthalene-1-sulfonylamino)-decyl]-9-aza-bicyclo[3.3.1]non-3-yl ester
InChi Key
RMGKFZJINTURGE-UHFFFAOYSA-N
InChi Code
InChI=1S/C39H56N4O6S/c1-42(2)36-20-14-19-34-33(36)18-15-21-38(34)50(45,46)40-24-11-9-7-5-6-8-10-12-25-43-29-16-13-17-30(43)27-32(26-29)49-39(44)41-35-28-31(47-3)22-23-37(35)48-4/h14-15,18-23,28-30,32,40H,5-13,16-17,24-27H2,1-4H3,(H,41,44)
SMILES Code
O=C(OC1CC(N2CCCCCCCCCCNS(=O)(C3=C4C=CC=C(N(C)C)C4=CC=C3)=O)CCCC2C1)NC5=CC(OC)=CC=C5OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 708.95 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Deng C, Xiong J, Gu X, Chen X, Wu S, Wang Z, Wang D, Tu J, Xie J. Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro. Oncotarget. 2017 Jun 13;8(24):38568-38580. doi: 10.18632/oncotarget.16930. PubMed PMID: 28445134; PubMed Central PMCID: PMC5503554. 2: Sun J, Ren SZ, Lu XY, Li JJ, Shen FQ, Xu C, Zhu HL. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors. Bioorg Med Chem. 2017 May 1;25(9):2593-2600. doi: 10.1016/j.bmc.2017.03.038. Epub 2017 Mar 19. PubMed PMID: 28363444. 3: Sørensen BS, Knudsen A, Wittrup CF, Nielsen S, Aggerholm-Pedersen N, Busk M, Horsman M, Høyer M, Bouchelouche PN, Overgaard J, Alsner J. The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types. Radiother Oncol. 2015 Sep;116(3):346-51. doi: 10.1016/j.radonc.2015.06.028. Epub 2015 Jul 10. PubMed PMID: 26169282. 4: Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao SD, Ran ZH. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. PLoS One. 2012;7(8):e41763. doi: 10.1371/journal.pone.0041763. Epub 2012 Aug 1. PubMed PMID: 22870247; PubMed Central PMCID: PMC3411563. 5: Zhou HM, Dong TT, Wang LL, Feng B, Zhao HC, Fan XK, Zheng MH. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition. World J Gastroenterol. 2012 Jun 7;18(21):2640-8. doi: 10.3748/wjg.v18.i21.2640. PubMed PMID: 22690072; PubMed Central PMCID: PMC3370000. 6: Shi F, Tao ZL, Luo SW, Tu SJ, Gong LZ. Scaffold-inspired enantioselective synthesis of biologically important spiro[pyrrolidin-3,2'-oxindoles] with structural diversity through catalytic isatin-derived 1,3-dipolar cycloadditions. Chemistry. 2012 May 29;18(22):6885-94. doi: 10.1002/chem.201200358. Epub 2012 Apr 13. PubMed PMID: 22505189. 7: Jiang H, Tang Y, Garg HK, Parthasarathy DK, Torregrossa AC, Hord NG, Bryan NS. Concentration- and stage-specific effects of nitrite on colon cancer cell lines. Nitric Oxide. 2012 May 15;26(4):267-73. doi: 10.1016/j.niox.2012.03.010. Epub 2012 Apr 5. PubMed PMID: 22504070. 8: Zeng C, Vangveravong S, Jones LA, Hyrc K, Chang KC, Xu J, Rothfuss JM, Goldberg MP, Hotchkiss RS, Mach RH. Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes. Mol Imaging. 2011 Dec;10(6):420-33. PubMed PMID: 22201533; PubMed Central PMCID: PMC4426860. 9: Wu JY, Xu XF, Xu L, Niu PQ, Wang F, Hu GY, Wang XP, Guo CY. Cyclopamine blocked the growth of colorectal cancer SW116 cells by modulating some target genes of Gli1 in vitro. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1511-8. doi: 10.5754/hge10765. Epub 2011 Jul 15. PubMed PMID: 21940310. 10: Chopra A. Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles . 2008 Nov 20 [updated 2008 Dec 17]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK23104/ PubMed PMID: 20641309. 11: Wang HT, Zhang Z, Fan M, Wang L, Dong GL. [Expression of CD112 in colon carcinoma tissues and cell lines and their clinical significance]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 May;26(5):477-9. Chinese. PubMed PMID: 20617580. 12: Hochwald SN, Lind DS, Malaty J, Copeland EM 3rd, Moldawer LL, MacKay SL. Antineoplastic therapy in colorectal cancer through proteasome inhibition. Am Surg. 2003 Jan;69(1):15-23. PubMed PMID: 12575774. 13: Maas IW, Boven E, Pinedo HM, Schlüper HM, Haisma HJ. The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines. Int J Cancer. 1991 Jul 9;48(5):749-56. PubMed PMID: 1830034.

View History

ZXN47262

ZXN47262